Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003880
Status:
TERMINATED
Last Update Posted:
2015-04-16
First Post:
1999-11-01
Brief Title:
Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-02
Start Date Type:
None
Primary Completion Date:
2001-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2001-08
Completion Date Type:
ACTUAL
First Submit Date:
1999-11-01
First Submit QC Date:
April 22 2004
Study First Post Date:
2004-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-15
Last Update Post Date:
2015-04-16
Last Update Post Date Type:
ESTIMATED